forstoringsglas

Search results

Vinge advises Vinci Concessions SAS and its subsidiary SunMind SAS in connection with its acquisition of Helios Nordic Energy AB from Magnora ASA, management and early investors

Helios Nordic Energy specialises in developing solar farms and batteries to store energy until they become Ready to Build in the Nordics and Baltics.
May 30, 2024

Vinge has advised Triton in connection with sale of shares in Ambea AB (publ)

In total, 7.6 million shares were placed at a price of SEK 64 per share, corresponding to a total value of approximately SEK 489 million.
May 27, 2024

Vinge has advised J2 Sourcing AB

Vinge has advised J2 Sourcing AB in connection with its acquisition of AAAAA Nordic AB, a Swedish retailer of electronic components.
May 23, 2024

Vinge advises Axcel in connection with the sale of Loopia Group to team.blue

Vinge advises Axcel V in connection with the sale of Loopia Group to team.blue, Europe’s leading digital enabler for entrepreneurs and SMBs and backed by Hg, a leading investor in European and transatlantic software and services businesses.
May 23, 2024

Vinge advises Ebie in connection with a capital raising

Vinge has advised the proptech company Ebie (Rentfair AB) in connection with a capital raising of SEK 8 million to further expand the business.
May 17, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of Theta

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of THETA Engineering AB (”Theta”).
May 15, 2024

Vinge advises Axcel and XPartners in connection with the acquisition of Projektkompaniet

Vinge has advised Axcel VII (“Axcel”) and XPartners Samhällsbyggnad (”XPartners”) in connection with the acquisition of Projektkompaniet i Motala AB (”Projektkomapniet”).
May 15, 2024

Vinge advises EQT Infrastructure VI on its public offer for OX2

EQT Infrastructure VI, through its indirectly owned subsidiary Otello BidCo AB, announces a recommended public offer to the shareholders of OX2 AB (publ) (“OX2”). The shares are admitted to trading on Nasdaq Stockholm, Large Cap.
May 13, 2024

Vinge advises PropTech Energy in connection with its acquisition of P2 Energi AB

PropTech Energy consists of the companies Ömangruppen and Axcell Fastighetspartner. Through the acquisition of P2 Energi AB, an energy consulting company within heating, ventilation and cooling technology, PropTech Energy strengthens its focus on energy efficiency.
May 06, 2024

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB.

Vinge has advised Ikano Bank AB (publ) in connection with the acquisition of a consumer credit unsecured loan portfolio from Nordnet Bank AB. The final purchase price will be based on the outstanding loan volume in the portfolio as of closing date. As of March 2024, the outstanding loan volume in the portfolio amounted to approximately SEK 3.8 billion. The acquisition is subject to customary regulatory approvals.
April 22, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024
Next